Literature DB >> 18593949

Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression.

Jun Yan1, Halime Erdem, Rile Li, Yi Cai, Gustavo Ayala, Michael Ittmann, Li-yuan Yu-Lee, Sophia Y Tsai, Ming-Jer Tsai.   

Abstract

Steroid receptor coactivator-3 (SRC-3)/AIB1 is a member of the p160 nuclear receptor coactivator family involved in development and cell cycle progression. We previously showed that SRC-3/AIB1 is required for prostate cancer cell proliferation and survival. Here, we reported that the elevated SRC-3/AIB1 expression is significantly correlated with human prostate cancer seminal vesicle invasion and lymph node metastasis. Furthermore, SRC-3/AIB1 is associated with increased prostate cancer cell migration and invasion. SRC-3/AIB1 is required for focal adhesion turnover and focal adhesion kinase activation. In addition, SRC-3/AIB1 directly regulates transcription of matrix metalloproteinase (MMP)-2 and MMP-13 through its coactivation of AP-1 and PEA3. Taken together, these data suggest that SRC-3/AIB1 plays an essential role in prostate cancer cell invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18593949      PMCID: PMC2826835          DOI: 10.1158/0008-5472.CAN-08-0955

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

Review 3.  Minireview: nuclear receptor coactivators--an update.

Authors:  Neil J McKenna; Bert W O'Malley
Journal:  Endocrinology       Date:  2002-07       Impact factor: 4.736

4.  Focal adhesion motility revealed in stationary fibroblasts.

Authors:  L B Smilenov; A Mikhailov; R J Pelham; E E Marcantonio; G G Gundersen
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

5.  FAK integrates growth-factor and integrin signals to promote cell migration.

Authors:  D J Sieg; C R Hauck; D Ilic; C K Klingbeil; E Schaefer; C H Damsky; D D Schlaepfer
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

6.  Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites.

Authors:  G Tardif; P Reboul; M Dupuis; C Geng; N Duval; J P Pelletier; J Martel-Pelletier
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

7.  Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2.

Authors:  Robert K Dearth; Xiaojiang Cui; Hyun-Jung Kim; Isere Kuiatse; Nicole A Lawrence; Xiaomei Zhang; Jana Divisova; Ora L Britton; Syed Mohsin; D Craig Allred; Darryl L Hadsell; Adrian V Lee
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

8.  Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model.

Authors:  Yanlin Yu; Glenn Merlino
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

9.  Junction protein shrew-1 influences cell invasion and interacts with invasion-promoting protein CD147.

Authors:  Alexander Schreiner; Mika Ruonala; Viktor Jakob; Jan Suthaus; Eckhard Boles; Fred Wouters; Anna Starzinski-Powitz
Journal:  Mol Biol Cell       Date:  2007-01-31       Impact factor: 4.138

Review 10.  Metalloproteinases: role in breast carcinogenesis, invasion and metastasis.

Authors:  M J Duffy; T M Maguire; A Hill; E McDermott; N O'Higgins
Journal:  Breast Cancer Res       Date:  2000-06-07       Impact factor: 6.466

View more
  62 in total

1.  ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.

Authors:  Ekaterina V Kalashnikova; Alexey S Revenko; Abigael T Gemo; Nicolas P Andrews; Clifford G Tepper; June X Zou; Robert D Cardiff; Alexander D Borowsky; Hong-Wu Chen
Journal:  Cancer Res       Date:  2010-09-23       Impact factor: 12.701

2.  Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.

Authors:  C Coarfa; W Fiskus; V K Eedunuri; K Rajapakshe; C Foley; S A Chew; S S Shah; C Geng; J Shou; J S Mohamed; B W O'Malley; N Mitsiades
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

Review 3.  Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.

Authors:  Christopher Foley; Nicholas Mitsiades
Journal:  Horm Cancer       Date:  2016-01-04       Impact factor: 3.869

Review 4.  Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis.

Authors:  John P Lydon; Bert W O'Malley
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

5.  The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer.

Authors:  Jean C-Y Tien; Zhaoliang Liu; Lan Liao; Fen Wang; Yixiang Xu; Ye-Lin Wu; Niya Zhou; Michael Ittmann; Jianming Xu
Journal:  Cancer Res       Date:  2013-05-06       Impact factor: 12.701

6.  Analysis of the human endogenous coregulator complexome.

Authors:  Anna Malovannaya; Rainer B Lanz; Sung Yun Jung; Yaroslava Bulynko; Nguyen T Le; Doug W Chan; Chen Ding; Yi Shi; Nur Yucer; Giedre Krenciute; Beom-Jun Kim; Chunshu Li; Rui Chen; Wei Li; Yi Wang; Bert W O'Malley; Jun Qin
Journal:  Cell       Date:  2011-05-27       Impact factor: 41.582

7.  SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization.

Authors:  Ping Yi; Weiya Xia; Ray-Chang Wu; David M Lonard; Mien-Chie Hung; Bert W O'Malley
Journal:  Genes Dev       Date:  2013-02-01       Impact factor: 11.361

8.  Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α.

Authors:  Wei Zhao; Cunjie Chang; Yangyan Cui; Xiaozhi Zhao; Jun Yang; Lan Shen; Ji Zhou; Zhibo Hou; Zhen Zhang; Changxiao Ye; Donald Hasenmayer; Robert Perkins; Xiaojing Huang; Xin Yao; Like Yu; Ruimin Huang; Dianzheng Zhang; Hongqian Guo; Jun Yan
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

9.  GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex.

Authors:  Bin He; Rainer B Lanz; Warren Fiskus; Chuandong Geng; Ping Yi; Sean M Hartig; Kimal Rajapakshe; John Shou; Liping Wei; Shrijal S Shah; Christopher Foley; Sue Anne Chew; Vijay K Eedunuri; Diego J Bedoya; Qin Feng; Takashi Minami; Constantine S Mitsiades; Anna Frolov; Nancy L Weigel; Susan G Hilsenbeck; Daniel G Rosen; Timothy Palzkill; Michael M Ittmann; Yongcheng Song; Cristian Coarfa; Bert W O'Malley; Nicholas Mitsiades
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

10.  Identification of SRC3/AIB1 as a preferred coactivator for hormone-activated androgen receptor.

Authors:  X Edward Zhou; Kelly M Suino-Powell; Jun Li; Yuanzheng He; Jeffrey P Mackeigan; Karsten Melcher; Eu-Leong Yong; H Eric Xu
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.